MONASH IVF GROUP LIMITED — Director's Dealing 2024

Apr 28, 2024

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Monash IVF Group Limited ABN 90 169 302 309

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Michael Damian Knaap
Date of last notice	1/12/2023

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

	Direct or indirect interest	Direct or indirect interest	Direct or indirect interest	Direct or indirect interest	Direct	Direct	Direct
	Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.				N/A
	Date of change				17 April 2024
	No. of securities held prior to change				Indirect interest of 150,655 OrdinaryShares held by MKN Family Holdings PtyLtdastrusteeforthePakhillSuperannuation Fund.Performance Rights•501,629 under the 2021 EquityIncentive Plan•466,166 under the 2022 EquityIncentive Plan•532,599 under the 2023 EquityIncentive Plan•517,433 under the 2024 EquityIncentive Plan
					•501,629Incentiv•466166	under the 2021e Pland th 2022
					,Incentiv	uner ee Plan
					•532,599Incentiv	under the 2023Plan
					•517,433	under the 2024
					Incentiv	e Plan
	Class				Ordinary Shares	and Performance Ri	ghts
L\353
		2544662

L\353254466.2

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number acquired	577,325 Ordinary Shares
Number disposed	501,629 Performance Rights under the
	2021 Equity Incentive Plan
Value/Consideration	Nil-vestingandconversionof
Note: If consideration is non-cash, provide details and estimatedvaluation	Performance Rights into Ordinary Shares
No. of securities held after change	Directinterestof577,325Ordinary
	Shares.
	Indirect interest of 150,655 Ordinary
	Shares held by MKN Family Holdings Pty
	LtdastrusteeforthePakhill
	Superannuation Fund.
	Performance Rights
	•466,166 under the 2022 Equity
	Incentive Plan
	•532,599 under the 2023 Equity
	Incentive Plan
	•517,433 under the 2024 Equity
	Incentive Plan
Nature of change	Conversion of Performance Rights to
Example: on-market trade, off-market trade, exercise of options, issueof securities under dividend reinvestment plan, participation in buy-back	Ordinary Shares (on a one-to-one basisplusadditionalOrdinaryShares
	representingdeemedreinvested
	dividends, as disclosed in the entity's 2021
	notice ofannualgeneral meeting)

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder	N/A
(if issued securities)
Date of change	N/A
No. and class of securities to which	N/A
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired	N/A

L\353254466.2

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Interest disposed	N/A
Value/ConsiderationNote: If consideration is non-cash, provide detailsand an estimated valuation	N/A
Interest after change	N/A

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required?	N/A
If so, was prior written clearance provided to allow thetrade to proceed during this period?	N/A
If prior written clearance was provided, on what date wasthis provided?	N/A

L\353254466.2

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 3